Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

In vitro killing of nosocomial pathogens by acid and acidified nitrite.

Rao A, Jump RL, Pultz NJ, Pultz MJ, Donskey CJ.

Antimicrob Agents Chemother. 2006 Nov;50(11):3901-4.

2.
4.

Adhesion of vancomycin-resistant enterococcus to human intestinal mucus.

Pultz NJ, Vesterlund S, Ouwehand AC, Donskey CJ.

Curr Microbiol. 2006 Mar;52(3):221-4. Epub 2006 Feb 18.

PMID:
16502294
5.

Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice.

Stiefel U, Harmoinen J, Koski P, Kääriäinen S, Wickstrand N, Lindevall K, Pultz NJ, Bonomo RA, Helfand MS, Donskey CJ.

Antimicrob Agents Chemother. 2005 Dec;49(12):5190-1. No abstract available.

6.

Growth in cecal mucus facilitates colonization of the mouse intestinal tract by methicillin-resistant Staphylococcus aureus.

Gries DM, Pultz NJ, Donskey CJ.

J Infect Dis. 2005 Nov 1;192(9):1621-7. Epub 2005 Sep 28.

PMID:
16206077
7.
9.

Mechanisms by which anaerobic microbiota inhibit the establishment in mice of intestinal colonization by vancomycin-resistant Enterococcus.

Pultz NJ, Stiefel U, Subramanyan S, Helfand MS, Donskey CJ.

J Infect Dis. 2005 Mar 15;191(6):949-56. Epub 2005 Feb 11.

PMID:
15717271
10.
11.

Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice.

Pultz NJ, Stiefel U, Ghannoum M, Helfand MS, Donskey CJ.

Antimicrob Agents Chemother. 2005 Jan;49(1):438-40.

12.
13.

Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centers.

Stiefel U, Paterson DL, Pultz NJ, Gordon SM, Aron DC, Donskey CJ.

Infect Control Hosp Epidemiol. 2004 May;25(5):380-3.

PMID:
15188842
14.
15.

Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice.

Stiefel U, Pultz NJ, Helfand MS, Donskey CJ.

Antimicrob Agents Chemother. 2004 Jun;48(6):2144-8.

16.
17.

Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients.

Bhalla A, Pultz NJ, Gries DM, Ray AJ, Eckstein EC, Aron DC, Donskey CJ.

Infect Control Hosp Epidemiol. 2004 Feb;25(2):164-7.

PMID:
14994944
18.
19.

Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice.

Stiefel U, Pultz NJ, Harmoinen J, Koski P, Lindevall K, Helfand MS, Donskey CJ.

J Infect Dis. 2003 Nov 15;188(10):1605-9. Epub 2003 Oct 23.

PMID:
14624388
20.
21.

Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients.

Bhalla A, Pultz NJ, Ray AJ, Hoyen CK, Eckstein EC, Donskey CJ.

Infect Control Hosp Epidemiol. 2003 Sep;24(9):644-9.

PMID:
14510245
22.

Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients.

Ray AJ, Pultz NJ, Bhalla A, Aron DC, Donskey CJ.

Clin Infect Dis. 2003 Oct 1;37(7):875-81. Epub 2003 Sep 12.

PMID:
13130397
23.

Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients.

Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, Rice LB.

J Microbiol Methods. 2003 Aug;54(2):249-56.

PMID:
12782380
24.

The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.

Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D.

J Biol Chem. 2002 Jan 11;277(2):1240-8. Epub 2001 Nov 13.

Supplemental Content

Loading ...
Support Center